References
Schlondorff D (1993) Cellular mechanisms of lipid injury in the glomerulus. Am J Kidney Dis 22:72–82
Radhakrishnan J, Appel AS, Valeri A, Appel GB (1993) The nephrotic syndrome, lipids, and risk factors for cardiovascular disease. Am J Kidney Dis 22:135–142
Austin HA, Illei GG (2005) Membranous lupus nephritis. Lupus 14:65–71
Ingulli E, Tejani A (1992) Severe hypercholesterolemia inhibits cyclosporine A efficacy in a dose-dependent manner in children with nephrotic syndrome. J Am Soc Nephrol 3:254–259
Radhakrishnan J, Kunis CL, D’Agati V, Appel GB (1994) Cyclosporine treatment of lupus membranous nephropathy. Clin Nephrol 42:147–154
Hallegua D, Wallace DJ, Metzger AL, Rinaldi RZ, Klinenberg JR (2000) Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature. Lupus 9:241–251
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fujinaga, S., Ohtomo, Y., Umino, D. et al. Treatment of steroid-resistant membranous lupus nephritis with plasmapheresis and low-dose cyclosporine. Pediatr Nephrol 22, 616–617 (2007). https://doi.org/10.1007/s00467-006-0356-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-006-0356-3